Litigation Details for MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)
✉ Email this page to a colleague
MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-05-18 |
Court | District Court, W.D. Pennsylvania | Date Terminated | |
Cause | 15:2 Antitrust Litigation | Assigned To | Mark Raymond Hornak |
Jury Demand | Plaintiff | Referred To | |
Patents | 7,476,652; 7,713,930; 7,918,833; 8,512,297; 8,556,864; 8,603,044; 8,679,069; 8,992,486; 9,011,391; 9,233,211; 9,408,979; 9,526,844; 9,533,105; 9,561,331; 9,604,008; 9,604,009; 9,610,409; 9,623,189; 9,717,852; 9,775,954; 9,827,379 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC
Biologic Drugs cited in MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-05-17 | 1 | Complaint (for Clerk of Court personnel only) | January 13, 2009, the PTO issued U.S. Patent No. 7,476,652 (“the ’652 patent”), entitled “Acidic Insulin Preparations… First Notice Letter Patents 7,476,652 Acidic Insulin Determined…reality, the only patents plausibly listed properly in the Orange Book were the 7,476,652 and 7,713,930… First Notice Letter Patents 7,476,652 Acidic Insulin Determined…ingredient) patents, drug product (formulation and composition) patents, and method of use patents.” Abbreviated | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |